Purvalanol a (cdk inhibitor) market to reach $1.01 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of cancer.
Read MorePurine analogues drugs market to reach $27.44 billion by 2030 at 11.0% CAGR, driven by rising prevalence of hematologic malignancies.
Read More
Pulmonary or respiratory drug delivery market to reach $114.23 billion by 2030 at 8.6% CAGR, driven by increasing prevalence of pneumonia.
Read More
Pulmonary drugs market to reach $74.14 billion by 2030 at 5.4% CAGR, driven by increasing prevalence of respiratory diseases.
Read More
Pulmonary arterial hypertension market to reach $13.75 billion by 2030 at 8.5% CAGR, driven by rising clinical trials for drug development.
Read More
Psychedelic drugs market to reach $13.67 billion by 2030 at 16.7% CAGR, driven by increase in cases of mental illnesses.
Read More
Psoriatic arthritis treatment market to reach $20.62 billion by 2030 at 9.5% CAGR, driven by increase in healthcare spending.
Read MorePsoriasis biosimilars market to reach $13.79 billion by 2030 at 11.0% CAGR, driven by rising psoriatic arthritis diagnosis rates.
Read More
Psoriasis market to reach $44.79 billion by 2030 at 9.3% CAGR, driven by rise in the prevalence of psoriasis patients.
Read More
Pseudomonas aeruginosa infection treatment market to reach $3.89 billion by 2030 at 8.0% CAGR, driven by increasing incidence of comorbidities such as pneumonia and cystic fibrosis.
Read More